Accretive Wealth Partners’s CATALENT, INC. CTLT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-8,888
Closed -$584K 117
2023
Q1
$584K Buy
8,888
+551
+7% +$34K 0.37% 82
2022
Q4
$375K Buy
8,337
+942
+13% +$51.2K 0.26% 93
2022
Q3
$535K Sell
7,395
-292
-4% -$29K 0.41% 81
2022
Q2
$825K Sell
7,687
-696
-8% -$70.9K 0.6% 53
2022
Q1
$930K Buy
8,383
+197
+2% +$20.6K 0.58% 61
2021
Q4
$1.05M Buy
8,186
+170
+2% +$21.8K 0.67% 56
2021
Q3
$1.07M Buy
8,016
+122
+2% +$15.2K 0.75% 52
2021
Q2
$853K Buy
7,894
+551
+8% +$59.1K 0.62% 67
2021
Q1
$773K Buy
7,343
+343
+5% +$38.3K 0.7% 65
2020
Q4
$728K Buy
+7,000
New +$678K 0.72% 57

Other funds holding CTLT

Accretive Wealth Partners's CTLT Position: Q2 2023 in Review

Accretive Wealth Partners sold out of CATALENT, INC. (CTLT) in Q2 2023, closing a stake of 8,888 shares — an estimated $584K sold.

Accretive Wealth Partners first reported a position in CTLT in Q4 2020 and held it in 10 quarters. The position peaked at $1.07M in Q3 2021. 441 funds tracked by Wall St. Rank hold CTLT as of Q2 2023.

  • Accretive Wealth Partners reported no remaining CATALENT, INC. position as of Q2 2023 after selling out during the quarter.
  • Accretive Wealth Partners sold 8,888 CATALENT, INC. shares in Q2 2023, an estimated $584K.
  • Accretive Wealth Partners first reported a position in CATALENT, INC. in Q4 2020 and held it in 10 quarters.
  • Accretive Wealth Partners's CATALENT, INC. position peaked at $1.07M in Q3 2021.
  • 441 funds tracked by Wall St. Rank held CATALENT, INC. as of Q2 2023.

Based on Accretive Wealth Partners's 13F filing for Q2 2023, filed 7 Aug 2023.